These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Hemodynamic evaluation of chronic uremic patients undergoing periodical hemodialytic treatment]. Lojacono L; Butti A; Castagneto M; Cagossi M; Salerni B; Pigliucci GM; Alquati P Chir Patol Sper; 1970 Dec; 18(5):411-33. PubMed ID: 5525552 [No Abstract] [Full Text] [Related]
9. [Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy]. Demelia L; Solinas A; Gogoni G; Marongiu F; Besson A Recenti Prog Med; 1982 May; 72(5):664-74. PubMed ID: 6753066 [No Abstract] [Full Text] [Related]
10. Changes of plasma concentration and elimination of various hormones by haemofiltration. Kramer P; Matthaei D; Arnold R; Ebert R; Kobberling D; McIntosh C; Schwinn E; Scheler F; Ludwig H; Reichel J; Spitella G Proc Eur Dial Transplant Assoc; 1977; 14():144-50. PubMed ID: 600950 [No Abstract] [Full Text] [Related]
11. The effect of renal transplantation on gastric acid secretion and on the serum levels of gastrin and group I pepsinogens. Paimela H; Härkönen M; Karonen SL; Tallgren LG; Ahonen J Ann Clin Res; 1985; 17(3):105-9. PubMed ID: 3901874 [TBL] [Abstract][Full Text] [Related]
12. [Serum gastrin in uraemic patients on intermittent haemodialysis following a test meal (author's transl)]. Pointner H; Flegel U; Schmidt P; Zazgornik J; Kopsa H; Waldhäusl W Wien Klin Wochenschr; 1974 Nov; 86(22):699-702. PubMed ID: 4460394 [No Abstract] [Full Text] [Related]
14. [Behavior of intradialysis curves of the PRA (Plasma Renin Activity) in a group of uremic patients during a periodic hemodialysis treatment]. Farinelli A; Bagni B; Squerzanti R; Candini GC; Gilli P Minerva Nefrol; 1973; 20(6):376-89. PubMed ID: 4366348 [No Abstract] [Full Text] [Related]
15. [Cholesterol-HDL and apoprotein A in a group of chronic uremic patients undergoing continuing hemodialytic treatment]. Bergesio F; Ciuti R; Manfredi M; Frizzi V; Zerboni R Minerva Nefrol; 1983; 30(3):165-73. PubMed ID: 6646491 [No Abstract] [Full Text] [Related]
16. Effects of omeprazole therapy on peptic disease and serum gastrin levels in hemodialysis patients. A preliminary study. Montemurro NE; Di Maggio A; Loperfido A; Franceschi M; Scatizzi A Clin Nephrol; 1993 Nov; 40(5):296-8. PubMed ID: 8281719 [TBL] [Abstract][Full Text] [Related]
17. [Value of the determination of alkaline phosphatase isoenzymes in patients undergoing periodic hemodialytic treatment]. Stefoni S; Campieri C; Bugiardini R; Biagetti L; Perini L Minerva Nefrol; 1979; 26(2):173-6. PubMed ID: 471344 [No Abstract] [Full Text] [Related]
18. [Oxalate behavior in patients undergoing periodic hemodialytic treatments]. Zucchelli P; Fusaroli M; Sasdelli M; Stallone C Minerva Nefrol; 1970; 17(6):184-6. PubMed ID: 5516052 [No Abstract] [Full Text] [Related]
19. Elimination of hormones through hemofiltration. Matthaei D; Kramer P; Langescheid C; McIntosh C; Schwinn G; Ebert R; Arnold R; Schauder G; Scheler F J Dial; 1977; 1(6):641-9. PubMed ID: 608873 [TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]